...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19

Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19

posted on Apr 12, 2021 05:15PM

Agreed, or at least multiple endpoints.

But then study would have to be longer.

Still worth knowing whether it helps patients during the time frame. Just wish it were designed to ask more than just that.

Share
New Message
Please login to post a reply